Hims & Hers Health (HIMS) Stock Analysis & Winston Score

Hims & Hers Health is an online healthcare company that connects patients with licensed doctors and then ships prescription or over-the-counter treatments directly to their homes. Its main products are medications and wellness items for hair loss, erectile dysfunction, weight loss, skincare, and mental health. The company sells directly to individual consumers, mostly in the United States, and operates entirely through its website and app.

Hims & Hers makes money by charging customers monthly or quarterly subscription fees for ongoing treatment plans, which creates recurring revenue. It operates almost entirely in the US and has grown quickly by keeping costs low through a telehealth model that cuts out traditional doctor offices and pharmacies. The biggest near-term growth driver is GLP-1 weight loss medications, but the company faces real risk if compounded versions of those drugs lose legal permission to be sold, which regulators are actively reviewing.

Winston Score History

Politician Trades

2 trades / 12mo

2 Congressional buys and 0 sells on HIMS in the last 12 months.

Unlock the full Smart Money Map — every trade plotted on the price chart with politicians, amounts and returns since each trade. Founder's Deal is $57/mo locked for life.

Unlock politician trades

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+28.4% YoY

YoY Growth Rate

Strong revenue growth

EPS Growth

-25.0% YoY

YoY Growth Rate

Earnings declining

Insider Activity

6.4%ownership

→ Flat

Insiders holding steady — not selling despite ability to

Cash Position

Cash flow positive

$229M cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Company generates more cash than it spends — no dilution risk from fundraising

Strong grower

Hims & Hers Health is growing revenue at 28% year-over-year. The Winston Score penalises unprofitable companies, but revenue at this pace tells a different story — this is a company still in "build mode."

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin

71.9%

Premium pricing power — 71.9% gross margin

Operating Margin

1.5%

Thin — 1.5% operating margin

ROCE

0.6%

Weak — 0.6% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY

+59.0%

Fast-growing sales (59.0% YoY)

EPS YoY

-2.1%

Earnings shrinking (-2.1% YoY)

Slight earnings drop. Typical near a cyclical low.

EPS Consistency

4/8 quarters

Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion

236%

Turns 236% of profit into real cash

FCF Margin

3.1%

Thin free cash flow (3.1%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity

2.07

Heavy debt load (2.07)

Interest Cover

100.00x

—

Comfortably covers interest (100.0x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)

63.0x

no trend

Expensive — P/E 63.0

P/E over 35. The market is pricing in heavy, sustained growth.

P/E vs Forward

+15.9

GROWING

Earnings expected to grow meaningfully — cheaper on forward P/E (63.0 → 47.1)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial